Objectives: Telehealth is promoted as a strategy to support self-management of long-term conditions. The aim of this systematic review is to identify which information and communication technology features implemented in mobile apps to support asthma self-management are associated with adoption, adherence to usage, and clinical effectiveness. Methods: We systematically searched 9 databases, scanned reference lists, and undertook manual searches (January 2000 to April 2016). We include randomized controlled trials (RCTs) and quasiexperimental studies with adults. All eligible papers were assessed for quality, and we extracted data on the features included, health-related outcomes (asthma control, exacerbation rate), process/intermediate outcomes (adherence to monitoring or treatment, self-efficacy), and level of adoption of and adherence to use of technology. Metaanalysis and narrative synthesis were used. Results: We included 12 RCTs employing a range of technologies. A meta-analysis (n ¼ 3) showed improved asthma control (mean difference À0.25 [95% CI, À0.37 to À0.12]). Included studies incorporated 10 features grouped into 7 categories (education, monitoring/electronic diary, action plans, medication reminders/prompts, facilitating professional support, raising patient awareness of asthma control, and decision support for professionals). The most successful interventions included multiple features, but effects on health-related outcomes were inconsistent. No studies explicitly reported adoption of and adherence to the technology system. Conclusion: Meta-analysis of data from 3 trials showed improved asthma control, though overall the clinical effectiveness of apps, typically incorporating multiple features, varied. Further studies are needed to identify the features that are associated with adoption of and adherence to use of the mobile app and those that improve health outcomes.
INTRODUCTION
Asthma is common and associated with significant morbidity. The World Health Organization reports that 235 million people worldwide currently suffer from asthma. 1 Supported self-management, including a personalized asthma action plan (PAAP), reduces morbidity. [2] [3] [4] [5] However, implementation is challenging. Practical, conceptual, and organizational barriers hinder the use of written PAAPs. Practical barriers include lack of time and resources (eg, no immediately available paper-based PAAPs). 6 Conceptual barriers include a mismatch between advice given by professionals and advice patients want on how to live with their asthma. 7 Organizational barriers include a lack of flexible systems for effective communication between professionals and patients. 4, 8 A mobile application (app) has the potential to support selfmanagement, though it needs to engage patients and encourage adherence. This year, it is predicted that 500 million people around the world will use a health care app, and 71% of all UK citizens have a smartphone. 9 Apps have penetrated into people's daily lives and are increasingly accepted as a tool to monitor health. However, many people stop using a health care app shortly after downloading it. 10 To realize the benefits of self-management, apps need to not only attract potential users, but sustain awareness of and adherence to ongoing use of the system. Previous research has been focused on clinical outcomes rather than on informing the development of system features that are attractive and adherent, such that patients continue to use the app in routine self-management. We therefore aimed to systematically review the literature to (1) assess clinical effectiveness, (2) characterize the features of the interventions and their association with outcomes, and (3) assess adoption and adherence to usage.
METHODS
The systematic review is registered with, and the protocol is available from, the PROSPERO database, registration number CRD42015016414. We followed the procedures described in the Cochrane Handbook for Systematic Reviews of Interventions. 11 
Search strategy
The search strategy, inclusion criteria, exclusion criteria, and analysis plan were specified in advance and are documented in the protocol. Table 1 summarizes the PICOS (population, intervention, comparison, outcome, and setting) strategy. We searched 9 databases and 2 trial registries, and undertook manual searches of key relevant journals. Search terms were asthma AND technology terms (3 categories: smartphone/tablet app, information and communication technology [ICT] services, devices and platforms) limited to RCTs and quasiexperimental studies with a date limit of 2000 (because this was the year of approval of the global technical specifications for third-generation [3G] cellular systems under the brand IMT-2000 by the International Telecommunication Union, which enable faster ICT application and services, including voice, fax, and Internet). 12 The detailed search strategy for MEDLINE and EMBASE are provided in Supplementary Appendix A.
Screening and Data Extraction
Titles and abstracts were screened by 1 reviewer (CyH), with 100 random titles checked by a second reviewer (HP) for training and quality control (with 100% agreement). The full text of all potentially eligible studies was retrieved and assessed against the inclusion criteria (see Table 1 PICOS description) by 1 reviewer (CyH), with a random sample of 20 papers reviewed by a second reviewer (TJ) initially with 75% agreement. The disagreement was due to different interpretations of the ICT interventions that would be included in the review. This was clarified in discussion with a third reviewer (HP), and we subsequently achieved 100% agreement. Two reviewers (CyH and HP) extracted data using a piloted data extraction sheet under the heading characteristics of the included studies (study method, demographics of participants, asthma severity, sample size, intervention duration, intervention, and control setting); features of the ICT; clinical outcomes (control and exacerbations); and adherence. Disagreements were resolved by discussion.
Risk of bias
Two reviewers (CyH and HP) assessed and documented the methodological quality of included studies using the methods detailed in section 8 of the Cochrane Handbook for Systematic Reviews of Interventions, 11 and used Review Manager 5.3 to record and generate a risk of bias graph. The overarching risk of bias was summarized based on the Cochrane risk of bias tool.
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Data synthesis and analysis
Meta-analysis
Heterogeneity of the included studies, such as measures used, intervention setting, and duration, was assessed to judge the appropriateness of performing meta-analysis. For groups of trials where metaanalysis was judged appropriate, mean difference was estimated using a fixed-effect model by R software, 13 and a pooled estimate with 95% confidence intervals reported. We used a fixed-effects method due to the small number of studies and so that the weightings could be dependent on within-study variability and study size rather than influenced by estimates of heterogeneity. If long-term and shortterm measures were presented, the long-term measures were taken to determine the treatment effect of the intervention.
Narrative synthesis
We performed narrative synthesis of heterogeneous studies. We plotted the app features and their associations with outcomes, sample size, and intervention duration on a bubble plot. This plot enables identification of a combination of features for effective clinical outcomes and/or adoption and sustainability.
Interpretation
The results of the data synthesis were discussed within the multidisciplinary team, which included expertise in e-health, ICT, and asthma self-management.
RESULTS

Included studies
The identified papers, the screening process, and the final number of studies included are detailed in the PRISMA flowchart ( Figure 1 ). In summary, out of 1919 papers, 14 were finally included, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] report-
Characteristics of included studies
The detailed table of characteristics is presented in Supplementary Appendix B and summarized in Table 2 . The 12 interventions [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] were conducted from 2005 to 2014 across the world: 2 in the Netherlands 15, 16 and 1 each in Australia, 14 Croatia, 25 China, 17 Denmark, 24 Portugal, 18 Singapore, 20 Taiwan, 19 Turkey, 27 the United Kingdom, 26 and the United States. 22 The studies are all RCTs, including a cluster RCT 14 and a crossover RCT. 18 The risk of bias across interventions is summarized in Figure 2 .
Participants
The number of participants for each intervention ranged from 16 to 300, and participants were recruited from primary and/or secondary care, with mild/moderate, severe persistent, or poorly controlled asthma, or patients admitted to the hospital. 
Comparisons
In most studies, the comparator was patients without access to any ICT system to support their asthma self-management, but 1 had 2 comparator groups (usual care and verbal self-management advice) 24 and 1 had 2 components (reminders and professional consultation skills training) compared or combined in 4 groups. 
Clinical outcomes
Clinical outcomes are summarized in Table 2 , with further details in Supplementary Appendix B.
Meta-analysis for asthma control Four publications 15, 16, 21, 26 reported asthma control using the Asthma Control Questionnaire (ACQ), 2 of which are included in the metaanalysis. One study, Araujo et al., 18 was excluded, because it used a shorter version of the ACQ (ACQ-5), which meant that it was not appropriate to combine this study with the other RCTs that used the full version of the ACQ. There was statistically significantly improved asthma control in the intervention group (mean difference À0.25, [95% CI, À0.37 to À0.12]), but the confidence interval did not include the minimum clinically important difference of 0.5 28 (see forest plot, Figure 3 ). In addition,
van Gaalen et al., 15 the follow-up study of Meer et al., 21 reported ACQ.
The between-group difference was maintained, albeit attenuated (À0.33, 95% CI, À0.61 to 0.05) for the 107 patients (60.8% of the participants in the original trial) who contributed data at 30 months.
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Narrative synthesis: asthma control In 6 of 11 studies 15, 17, 19, 24, 25 researchers reported improved asthma control over time scales of 3-30 months in the intervention groups. The interventions consisted of 2 mobile apps, 2 web applications, and 2 SMSs. A common feature was an electronic diary that could be shared with health care professionals for regular review. Of the 6 interventions, 1 25 was at low risk of bias, while 5 15, 17, 19, 24 showed unclear risk of bias.
Quality of life
Although 8 studies [14] [15] [16] [17] [18] [19] 24, 26 reported asthma-related quality of life, heterogeneity of study design and outcome measure precluded meaningful meta-analysis. Four interventions 15, 17, 19, 24 (50%) found that quality of life improved over 6-30 months. The interventions were Web applications with common features of an electronic diary, an action plan, and regular supportive reviews by health care professionals. Of the 4 effective interventions, 1 study was at low risk of bias 15 and 3 were at unclear risk of bias.
17,19,24
Exacerbations Five interventions 14, 20, 22, 25, 26 reported 6 outcomes relevant to exacerbations (hospital admissions, emergency department visits, unscheduled visits to practices, steroid courses, numbers of patients with 1 or more severe exacerbations, and practice visits triggered by an exacerbation alert generated by the ICT system). The interventions were mobile app, smart inhaler, handheld asthma monitoring device, and SMSs. None of the interventions were associated with a significant reduction in exacerbation-related outcomes. Three of the studies 22, 25, 26 presented data on proportion of patients with a hospital admission over 3-6 months, but the rates were very close to zero (0.02%, 0.17%, and 0.25%), so that meta-analysis was unhelpful. Of 5 interventions, 3 studies were at unclear risk of bias, 14,22,25 1
was at low risk of bias, 26 and 1 was at high risk of bias. 20 
Application features in the included interventions
Characteristics of the application features There were 10 application features in the 12 interventions, details of which are summarized in Table 3 . These were categorized into 7 themes: education, asthma diary, action plan, medication adherence, facilitating professional support, raising patients' awareness of asthma control, and decision support for the health care professional. Eleven of the 12 interventions included more than 1 feature. Four interventions included 5 or more features. Eight included an asthma diary, 9 an action plan, and 11 professional support. Only 1 intervention 24 contained a decision support system for the health care professional. Application features associated with health-related outcomes of the included interventions To synthesize the impacts of the application features on healthrelated outcomes while considering the sample size and duration of each study, we prepared bubble plots (see Figures 4 and 5) . The effect on asthma control and quality of life was inconsistent, although there were no examples of harm. There was no significant clinical impact (either positive or negative) on exacerbations. 14, 20, 22, 25, 26 Most of the interventions included multiple features such as self-monitoring and action plans, but outcomes were variable. One study that focused on medication adherence with reminders and treatment logs improved adherence but none of the clinical outcomes. 14 One study that incorporated feedback and decision support for physicians 24 improved asthma control and quality of life.
Adoption and adherence to usage
Action plan ownership Within the 12 studies, only 1 24 reported action plan ownership in the 3 study groups. A significant increase in use of an action plan from baseline to end of study was reported in both intervention groups (Web-based monitoring, from 2% to 88%; Web-based specialist support, from 3% to 55%) compared to a smaller increase in the usual care group (from 0% to 6%).
Self-efficacy
Only 1 study reported self-efficacy. 26 The intervention was a mobile app that provided patients with an asthma diary, an action plan, and structured support from health care professionals for 6 months. No significant difference was reported in self-efficacy between the intervention and control group, which had similar professional support (KASE-AQ, self-efficacy score; mean difference 2.0 [95% CI,
À0.3 to 4.2]).
Adoption of and adherence to intervention There were no interventions that explicitly reported adoption of the ICT system, and it is impossible to gauge directly in a trial because, by definition, everyone in the intervention group received the ICT system. However, usage data may give an indication of the general level of interest in the ICT system, and adherence to the system may be inferred by looking at differential attrition rates in the intervention/control groups and reasons for withdrawal. Eight studies reported the data transmitted during the studies and/or reasons for attrition because of problems with the ICT system. Details are summarized in Table 2 .
Of the 8 interventions, only 2 (Araujo et al. 18 and Jacobson et al. 22 ) reported the data transmitted in the control and intervention groups. Araujo et al. 18 reported that there was no significant difference in adherence to electronic peak flow monitoring between the Web application group and paper-based monitoring. At the end of the trial, 12 of the 18 participants in the crossover trial were "very interested" in continuing to monitor their asthma using the Web application. Another study, Jacobson et al., 22 reported 2.85 times more data received from the intervention group than the paperbased group. Araujo et al. 18 used a Web application, while Jacobson et al. 22 used a customized embedded system. They both had the application features of an action plan and facilitated support from health care professionals. Three interventions explicitly reported the number of patients who were lost to follow-up or withdrew because of problems with the ICT system; these were Ryan et al. 26 (n ¼ 5, "telemonitoring problem"), Liu et al. 19 (n ¼ 4, "couldn't use the app"; n ¼ 2, had a "problem with the app"), and Prabhakaran et al. 20 (n ¼ 1, "dissatisfied with the service"). Ryan et al. 26 and Liu et al. 19 were mobile app interventions while Prabhakaran et al. 20 was an SMS application. They both had an asthma diary, an action plan, and support from health care professionals. 
DISCUSSION
Summary of findings
Our meta-analysis of 3 trials showed a positive effect on asthma control, and a 30-month follow-up study showed that this effect was sustained, albeit attenuated. Within the 12 studies, 12-27 we identified 10 common features grouped into 7 themes. Most of the interventions included multiple features of self-monitoring and action plans. The effect of the features on health-related outcomes (asthma control, quality of life, exacerbations) and medication adherence varied, though importantly there were no examples of harm. There was no significant clinical impact (either positive or negative) on exacerbations. 14, 20, 22, 25, 26 The impact of the different features on adoption of and adherence to the system was not possible to gauge directly, but reasons for attrition highlighted the importance of reliable user-friendly systems.
Strengths and limitations
Our systematic review provides an evidence-based review explicitly of the ICT features included in recent interventions (since 2000) and their associations with asthma health-related outcomes. We performed an updated search in early April 2016. Nevertheless, in the fast-moving field of ICT, this may still have missed some contemporary features.
There are some methodological limitations. First, due to resource and time constraints, a single review was performed at the initial screening stage, although we implemented robust training and quality control processes during review in order to minimize potential inaccuracies. Second, we did not translate papers that were not written in English, though only 1 study (Kokubu et al. 29 in Japanese) was identified. Third, the included trials focused primarily on health outcomes and the interventions included multiple features, so they could not provide evidence on the individual application features associated, though our grouping of the features may be useful for further research.
Interpretations in relation to published literature suggested that providing instruction on better health care management and sharing data with a designated professional were the most valuable features of health care apps for users. Interventions with these features (see the bubble plot, Figures 4 and 5) found that impact on asthma control and quality of life varied, and there was no significant impact on exacerbations. The inconsistent clinical outcomes from the 11 studies, despite incorporating similar features, highlight the importance of context in determining whether an intervention is effective. This resonates with the findings of a systematic review of studies implementing supported asthma self-management, which concluded that a whole-systems approach (ie, explicitly addressing patient, professional, and organizational factors) showed the most consistent improvement in clinical outcomes. 33 Of the 12 studies in this review, the 11 studies with application features focused solely on patients showed inconsistent impacts on clinical outcomes; the 1 study with features targeted at both patients and health care professionals improved both asthma control and quality of life.
Implications for clinical care and future research
Our findings suggest that mobile apps have the potential to be effective in supporting self-management and are an option that may be preferred by some people and their clinicians. However, these studies of multifaceted interventions did not provide clear evidence on which of the range of ICT features were essential for effectiveness. Furthermore, the lack of technical specifications of the ICT systems evaluated in the clinically focused publications with health outcomes did not allow understanding of the design factors of the systems, which may have affected how they operated or were used by patients and professionals. Finally, no matter how well designed the ICT is, it will not be effective if patients do not adopt it and continue to use it. The challenge for researchers and technology developers now is to explore the dynamic needs and preferences of people with asthma and evaluate the features associated with improved adoption of and adherence to mobile apps.
CONCLUSION
Mobile apps, incorporating an action plan and other selfmonitoring features, are an effective option for supporting selfmanagement, which resonates with the widespread adoption of technology in this digital era. However, there is insufficient evidence to identify the important application features that attract and encourage patients to continue using the app. Further development in this field will require robust studies that not only establish the long-term effectiveness but also evaluate the specific features associated with improved adoption of and adherence to the mobile app. 
